MAPT and Alzheimer disease: Although amyloid and tau remain the dominant pathogenic models in AD, increasing evidence highlights the influence of systemic metabolic factors, such as adipokine signaling, including leptin, on brain vulnerability decades before clinical onset [251] (Figure 2).